Sitemap
Pages
- HCP Expense Auditing Survey Report
- Compliance & Commercial Success in HCP Engagements
- HCP Expense Auditing Survey 2024
- Adapting to the DOJ’s 2024 ECCP Guidance
- Sample team page
- qordata Brand Assets
- Sample draft
- Expense Monitoring and Auditing Solution for a Leading Pharmaceutical Company
- Compliance Risk Assessment
- Risk Assessment Tool
- HCP Meal Limit Survey 2024
- Conferences
- Global Spend Transparency Reporting
- Strategy Guides
- CMS Open Payments Audits: Why and How to Be Audit Ready?
- About Us
- Thought Leadership
- Grants & Sponsorships Management Solution
- 6-Step Guide to Modernize Your Compliance Monitoring Program
- qorAI
- MonitorGPT
- CMS Genie
- 6 Steps to Elevate Your Compliance Program Effectiveness
- 7 Key Steps For Compliant HCP Engagements
- CMS Open Payments Reporting Solution
- 6 Steps to Modernize your Compliance Monitoring Program
- Modernize Your CMS Open Payments Reporting Program
- 6 Steps to Elevate Your Compliance Program Effectiveness
- Modernize Your CMS Open Payments Reporting Program
- 7 Key Steps for Compliant HCP Engagements
- Modernize Your CMS Open Payments Reporting Program
- Sitemap
- AI-Powered Comprehensive Expense Monitoring & Auditing for Life Sciences Compliance
- Live Monitoring Checklists
- Monitoring Plan Services For Life Sciences Companies
- CMS Open Payments Reporting Solution
- Global HCP Engagement Solution | Manage & Mitigate Risks
- HCP Fair Market Value Tiering & Compensation Model
- CMS open payments reporting service brochure
- Enterprise Risk Analytics
- Customer Advisory Services
- Download Survey Gated
- Upsides of Embracing Compliance Modernization for Life Sciences Companies
- Thank You
- Webinar: Importance of Expense Monitoring and Auditing in Life Science Commercial Compliance
- Setting Up Your Compliance Program
- Legal Services
- Sample Page
- Oregon Transparency Reporting Requirements
- Thank You for Signing Up
- Webinar: Mastering HCP Engagement Strategies
- Partners
- Contact Support – qordata
- State Price Transparency Reporting
- Download Brochures Gated
- Aggregate Spend Reporting Solution Product Video Playback
- Aggregate Spend Reporting Solution Product Video
- Download Brochure
- Data-driven Compliance Platform
- qordata – Data-Driven Compliance Platform
- Aggregate Spend Reporting
- AI-Powered Risk Based Monitoring – qordata
- Global Risk Assessment – qordata
- Compliance Analytics
- GLobal Compliance Monitoring
- Webinar: Enhancing Compliance Monitoring with Transparency Data
- Expense Monitoring and Auditing Product Video Playback
- Expense Monitoring and Auditing Product Video
- Expense Monitoring and Auditing Solution
- Blogs
- Harnessing and Applying the Power of Data to Drive Compliance Effectiveness and Efficiency
- Compliance Monitoring & Risk Based Scoring (RBS) for A Drug Manufacturing Company
- Compliance Insights for a Biotechnology Company
- On-demand Data-Driven Compliance: Applying “Thoughtware and Software” to Achieve Competitive Advantage in Life Science
- State Price Transparency Reporting
- Data-Driven Compliance: Your Competitive Advantage in Life Sciences and Biotech
- On-Demand: Open Q&A for CMS Submissions
- On-Demand: Analyzing the OIG Special Fraud Alert on Speaker Programs
- On-Demand: Agile journey for Pharmaceuticals with Scaled Agile Framework Safe
- On-Demand: Power of Transparency Data for Compliance Monitoring
- On-Demand: PhRMA code update and its implications
- On-Demand: Simplifying Complex Compliance Monitoring Requirements
- On-Demand: Simplifying Complex Compliance Monitoring Requirements: Navigating Today’s Environment
- Thank You Case Study
- Whitepaper
- Whitepaper | Thank You
- Case Studies
- Simplifying Complex Compliance Monitoring Requirements: Navigating Today’s Environment
- Transparency Reporting for A Biotechnology Company
- Webinar August 24 – Download Pack
- Webinar | Thank You
- When Life Sciences Compliance Demand Advancements: A Look at The Future
- Simplifying the Complex Compliance Monitoring Requirements – Development
- Transparency Reporting for A Global Medical Device Company
- Thank You
- Schedule your meeting – qordata
- Data Driven Monitoring for Speaker Programs
- PhRMA code update and its implications – Download Pack
- PhRMA code update and its implications
- Webinar 2021 – design
- Webinar: Power of Transparency Data for Compliance Monitoring
- Power of Transparency Data for Compliance Monitoring
- qordata giveaways – PCC 2021
- How RPA is transforming Pharmaceutical Industry
- FDA Pharmaceutical Sample Report – Transparency Reporting
- US State | Vermont Transparency Reporting Requirements
- Nevada – Transparency Reporting – qordata
- Minnesota – Transparency Reporting – qordata
- Massachusetts – Transparency Reporting – qordata
- District of Columbia – Transparency Reporting – qordata
- US State | Connecticut Transparency Reporting Requirements
- U.S Federal Transparency Reporting Requirements
- Information Security Certification
- Special fraud alert on speaker programs
- What’s new in DOJ’s revised guidance
- Industry’s Best Practices with Christopher Gingras
- Terms of use
- Compliance Conversation with Seth and Sergio – re_run
- Promotional Activities in the Era of Social Distancing – Re-Run Webinar Sarah
- HCP Interactions and Reporting – Sharon
- Evaluation of Corporate Compliance Program
- Data Privacy
- qordata Team
- Jobs
- Post a Job
- Contact
Webinars
- Expense Auditing: Identifying False and Erroneous HCP Expense Reports
- Risk-Based Monitoring Using AI and Analytics
- Automating Expense Monitoring & Auditing through AI
- Leveraging Technology for Compliant HCP Engagements
- Remediation Strategies for Life Sciences Compliance
- Preparing for CMS Open Payments Audit
- Critical Data Points for Aggregate Spend Reporting
- Importance of Expense Monitoring and Auditing in Life Science Commercial Compliance
- Mastering HCP Engagement Strategies
- Enhancing Compliance Monitoring with Transparency Data
- Simplifying Complex Compliance Monitoring Requirements: Navigating Today’s Environment
- Simplifying Complex Compliance Monitoring Requirements
- Data-Driven Monitoring for Speaker Programs
- PhRMA code update and its implications
- Power of Transparency Data for Compliance Monitoring
- How RPA is transforming Pharmaceutical Industry
Blogs
- Compliance Essentials: Data-Driven HCP Engagements
- Enhancing Commercial Compliance Operations Through AI-Driven Solutions
- 7 Ways AI Chatbot Transform CMS Open Payments Data into Actionable Intelligence
- Contextual Analytics: The Foundation of a Data-Driven Compliance Program
- Commercial Compliance Programs: Everything You Need to Know
- Using Artificial Intelligence To Manage Life Sciences Compliance
- Overview of the OIG’s General Compliance Program Guidance 2023
- Leveraging Automated Expense Monitoring & Auditing for Compliance
- The 7 Steps to Ensure Compliant Healthcare Professionals (HCP) Engagements
- 5 Best Ways for Compliance Officers to Successfully Manage Commercial Compliance
- 6 Steps to Increase the Effectiveness of Your CMS Open Payments Reporting Program
- Open Payments Reporting: Frequently Asked Questions (FAQs) for Compliance Officers
- 2024 Compliance Roadmap: Strategic Monitoring Planning for Leaders
- A Roadmap for New Chief Compliance Officers: 10 Essential Steps
- Continuous Improvement Is The Leading Success Indicator for Compliance Programs: Here’s Why?
- How to Leverage Data to Monitor Regulatory Compliance in Your Organization
- Top 5 Compliance Priorities for CCOs in 2024
- Why New Regulatory Demands Require an Advanced Approach to Compliance
- Review Data Collection Processes for Compliant Spend Reporting
- 8 Ways to Ensure Compliance Success with Analytics
- How Data and Technology is Transforming the Role of Compliance Professionals
- How To Handle Government Investigations: Showcasing Audit Readiness
- Data & Compliance: What You Know Can Empower You
- How Digitalized Compliance Monitoring of Speaker Programs Ensures Effective Adherence to Anti-Kickback Statute
- Detecting & Preventing Kickbacks to HCPs Using Compliance Monitoring
- 7 Tips for Starting Your Life Sciences Compliance Analytics Program
- 4 Things to Know About the False Claims Act (FCA)
- 5 Advantages of Comparing Your Spend Data With The Life Sciences Industry’s Data
- Utilizing Data Visualization To Enhance Life Sciences Compliance
- Conflicts of Interest and CMS Open Payments: Safeguarding Transparency in the Life Sciences Industry
- Guide To Conducting Compliance Gap Assessment To Improve Regulatory Compliance
- The Evolving Role of Compliance Officers in the Life Sciences Industry
- A Step-By-Step Guide to Solving Open Payments Disputes
- The 7 Elements of An Effective Compliance Program
- The Facts About Open Payments Data in 2024
- The Importance of Compliance In The Pharmaceutical Industry
- Top 7 Considerations for Life Sciences Compliance
- Natures of Payment: Payments Categories Explained
- The Life Sciences Industry’s Regulatory Outlook in 2024
- 8 Best Practices To Ensure Compliance with Open Payments Sunshine Act
- The Importance of Risk Mitigation in the Life Sciences Industry
- Sunshine Act Reporting/Transparency Reporting: Explained
- Data-Driven HCP Engagement Strategies for Life Sciences Companies in 2024
- The Latest Trends in Expense Monitoring & Auditing in 2024
- Reducing Critical Risks Through Data-Driven Compliance Monitoring
- Transparency Reporting in Life Sciences: Unifying Efforts Across 3 Core Areas
- $100K False Claims Act settlement After Company Violates Anti-Kickback Statute
- Maintaining Value in Pharmaceutical Compliance by Modernizing Through Digital
- Is Adaptability Really an Underrated Compliance Skill? Let’s Find Out
- Unlock Success in Speaker Programs with Data-Driven Compliance
- Building A Dynamic Compliance Program? Here Are A Few Key Considerations For You
- Life Sciences Compliance Made Simpler: Compliance at Its Core
- U.S. Transparency Reporting: The Newly Added Covered Recipients
- Ask Yourself These Five Questions from The DOJ’s Standpoint
- Streamlining HCP Interactions with Data-Driven Compliance Solutions
- Taking the Transformative Route to Improve Compliance
- Reducing Compliance Risk with qordata’s Data-Driven HCP Engage
- HCP Engagement Rates on the Rise Due to Inflation
- Visualizing Compliance Data: The Power of Integrated Dashboards
- Analyzing CMS Open Payments Data 2021: Trends and Insights
- Key Insights from the OIG’s Special Fraud Alert on Speaker Programs
- Life Sciences Compliance: Shedding Light on Some Recent Settlements
- Minimizing Risks: A Guide to Ethical HCP Engagement
- Unveiling the Power of Data-Driven Compliance in Life Sciences
- Why a Compliance Program Should Be Data-Driven?
- Is Managing Compliance Really That Difficult in Life Sciences?
- The Imperativeness of Compliance in Life Sciences
- Maximizing Value & Insights Through Compliance Monitoring
- Understanding the Significance of Compliance Monitoring in Life Sciences
- 5 Ways to Meet Aggregate Spend Reporting Deadlines
- The Vital Role of Compliance Partnerships in Life Sciences
- 4 Steps to Enhancing the Effectiveness of a Compliance Program
- 5 Essential HHS Laws for Life Sciences Companies
- Navigating Compliance Challenges in Life Sciences: Strategies and Solutions
- Reimagining Compliance Modernization in the Life Sciences Industry
- Revolutionizing Compliance: Top 6 Tech Trends
- The Revolution of Data in the Life Sciences Industry
- The Fusion of Transparency and Innovation in the Life Sciences Industry
- 5 Key Qualities Of A Transparency Reporting Partner You Should Look For
- 5 Strategic Ways to Navigate Transparency Reporting Challenges in 2022
- Aggregate Spend Data in the Life Science Industry: An Overview
- Leveraging Aggregate Spend Data in Life Sciences: Uncover Competitive Insights
- Navigating the Key Shift in PhRMA Code
- CMS Requirements for Life Sciences Companies in 2022
- 3 Key Strategies for Effective Risk-Based Monitoring
- Quick Review of PhRMA Code Updates and Implications in 2022
- FAQs on PhRMA Code Update: How Does It Apply to Me?
- PhRMA Code Updates and Implications for Life Sciences Compliance
- qordata Ranks 1351st on 2021 Inc. 5000 List of Fastest-Growing Companies in the US
- Why Open Payments Matters for Life Sciences Companies
- Are you prepared for the OIG’s Special Fraud Alert for Speaker Programs?
- Insights on OIG Special Fraud Alert for Speaker Programs by Sarah DiFransesca and Leslie Restanio
- HCP Meal Limits Survey 2020: Key Findings and Insights
- Webinar: DOJ’s Revised Guidelines for Evaluating Corporate Compliance Programs
- Key Risk Areas in Speaker Programs and HCP Meals: Downloadable Guide
- Sunshine Act Reporting Deadlines for 2024: Federal and State Requirements
- The 4 Most Common Sunshine Act Reporting Mistakes You Should Avoid
- CMS Open Payments 2020 Changes: What Compliance Professionals Need to Know
- OIG Reviews Open Payments Data: What Manufacturers and GPOs Need to Know
- Establishing Causality: Physician Spend and Pharma Performance Analysis
- Understanding Correlation vs. Causality in Compliance Analysis
- Qualitative Concerns in the Life Sciences Transparency/Compliance Environment: Part I
- CMS Reporting Structure Changes for Life Sciences Companies
- Measuring Compliance with Transparency Metrics
- Penalties for Failure to Report or Erroneous Submissions in Sunshine Payments
- The Crucial Role of Technology in Achieving GDPR Compliance
- EU Pharma’s Wake-Up Call: Lessons from Insys
- Pharma Compliance: From Desk Jobs to Frontline Warriors
- This Life Sciences Company Is About To Get A Spooky Surprise This Christmas
- The Evolution of Data Privacy in the EU & USA
- Debating Transparency Beyond Consent Rates – Part II
- Debating Physician Consent Rates in Pharma Transparency
- Shifting Attitudes Toward Pharma Spend Disclosure
- Pharma Compliance Workflow: 2 Phases | Reporting & Analysis
- Here’s A Quick Quiz To Check Your Compliance Analytics Acumen
- Leveraging Data Visibility To Steer Compliance In The Right Direction
- Surprising Figures From CMS Open Payments Data 2016
- The Significance of Context in CMS Reporting
- Instant Insights From CMS Open Payments Data 2016
- qordata Leverages Its Analytics Capabilities To Uncover Critical Insights
- Pharma Associations and Transparency in Germany
- The Impact of Pharma Disclosure on Public Healthcare
- 7 Tips for Starting Your Pharma Analytics Program
- The Priority of Data Scrutiny in Compliance
- Webinar: Busting Pharma Analytics Myths with Merck USA
- Merck USA’s Compliance Analytics Journey: A Case Study
- Pre-CMS Submission Analytics: Vital for Compliance
- Are Pharma Analytics On Your Company’s Radar? (Poll Results May Surprise You)
- Do The Benefits Of Data Analytics Outweigh The Burden?
- qordata’s CEO Attends The 5th Annual Compliance & Transparency Conference
- Global Transparency Compliance: Getting Your Data in Order is Necessary
- Managing Consent With a Real-Time Database Solution
- FCA Civil Penalties Increased by the Department of Justice Again
- Open Payments Systems Become Available for Registration & Data Submission
- The Risk-Focused Future of Compliance in the Life Sciences Industry
- Will the ACA repeal impact Open Payments?
- New Transparency Reporting Obligations Enacted by the Belgian Government
- Shire Settles Kickback Allegations with $350 Million
- A Pharmaceutical Company’s Offices in Athens Were Raided by Prosecutors
- Unlocking Pharma Insights with Open Payments Analytics
- How the U.S. Department of Justice Recovered $4.7 Billion in 2016?
- How EU Member Counties Are Approaching the Issue of Consent Under Data Protection Laws
- Execs & Physicians at Doc-Owned Hospital Chain Indicted in Alleged Kickback Scheme
- Open Payments Data Being Used by Feds to Uncover Fraud – Are You Willing to Take the Risk of Not Knowing Your Data?
- Country Consent Rates Across the EU
- Highlights of the 3rd Annual Global Compliance Congress for Life Sciences
- Challenges in Seeking HCP/O Consent Under the Data Protection Laws of The EU
- Sunshine Act Reporting Challenges & How to Tackle Them
- Listing Down the Challenges in Implementing Transparency In the EU
- Highlights of the 17th Annual Pharma and Medical Device Compliance Congress
- Tackling Non-Compliance and Fraud with Compliance Data Analytics
- Highlights of the 4th Annual Pharma Compliance Europe Congress
- This Company Paid $28.1 Million for Violating The Anti-kickback Statute and False Claims Act
- Do Publish Spend Records Reveal the Story Behind the Transaction?
- $513 Million Penalty Imposed on a Hospital for Illegal Patient Referral Payments
- 17th Annual Pharma and Medical Device Compliance Congress
- EFPIA Transparency Directive: What to Expect in The Future?
- Rising Healthcare Fraud Penalties Make It Important for Life Sciences To Understand Their Data
- EFPIA Transparency Directive: What Should A Transparency System be Based On?
- 4th Annual Pharma Compliance Europe Congress
- DOJ and CMS Increasing Focus on Health Care Fraud
- CMS to Add Data Analytics Lead to Its Employees Pool
- Transparency Data and Law Enforcement Authorities: The Dynamic Duo
- CMS Data Deep Dive: $15,000 for a Single Meal
- Indictment of Novartis Korea Executives Over Rebates
- Highlights of 10th Annual Forum on Transparency & Aggregate Spend
- Understanding the Sunshine Act and Open Payments
- Medical Device Manufacturer: Fined $646M FOR Paying Kickbacks to Hospitals
- DOJ Doubles FCA Penalties for Life Sciences Companies
- qordata Adds 2015 Open Payments Data to its Open Payments Analytics Software
- Using Open Payment Data Analytics to Assess Compliance Risk
- Off Label Spending – Using Transparency Data to Sniff Out Clues
- Next Generation Compliance: Using Analytics to Reduce Compliance Risks
- Importance and Responsibilities of Ethics and Compliance Officers for Pharma Manufacturers